Skip to main content
Premium Trial:

Request an Annual Quote

Celera Signs Five New Academic Subscribers to its Databases

NEW YORK, July 19 - Celera said Thursday it has signed five new subscribers to its database, and has expanded its subscription agreement with a current subscriber, the University of Texas Southwestern Medical Center.

The new subscribers are the University of Alabama at Birmingham, Case Western Reserve University School of Medicine, Fred Hutchinson Cancer Research Center, University of Oxford in England, and Pennington Biomedical Research Center at Louisiana State University. 

The University of Texas Southwestern Medical Center at Dallas has now expanded its existing subscription to Celera's databases to include the University of Texas Health Science Centers at Houston and San Antonio, and the University of Texas Medical Branch.

All of the institutions signed multi-year subscriptions for access to all of Celera's proprietary human, mouse, and SNP databases through the Celera Discovery system, a web-based interface that includes software tools for searching and analyzing Celera's data.

The cost of the subscriptions were not disclosed, but in the past, Celera has charged academic subscribers between $7,000 and $15,000 a year per scientist using the databases.

Last week, Celera raised eyebrows when it announced that the National Cancer Institute, of the National Institutes of Health (NIH), had signed an agreement allowing individual researchers to access the databases. The National Human Genome Research Institute, Celera's rival in sequencing the human genome, is also within NIH.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.